Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Use of a Geographic Information System to create treatment groups for group-randomized community trials: The Minnesota Heart Health Program.

Krzyzanowski B, Manson SM, Eder MM, Kne L, Oldenburg N, Peterson K, Hirsch AT, Luepker RV, Duval S.

Trials. 2019 Mar 28;20(1):185. doi: 10.1186/s13063-019-3284-9.

2.

ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.

Bailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ, Wann LS, Bailey SR, Dao T, Aronow HD, Fazel R, Gornik HL, Gray BH, Halperin JL, Hirsch AT, Jaff MR, Krishnamurthy V, Parikh SA, Reed AB, Shamoun F, Shugart RE, Yucel EK.

J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. doi: 10.1016/j.jacc.2018.10.002. Epub 2018 Dec 17. No abstract available.

PMID:
30573393
3.

Use of online promotion to encourage patient awareness of aspirin use to prevent heart attack and stroke.

Southwell BG, Eder M, Finnegan J, Hirsch AT, Luepker RV, Duval S, Russell C, O'Byrne S.

J Epidemiol Community Health. 2018 Nov;72(11):1059-1063. doi: 10.1136/jech-2018-210676. Epub 2018 Aug 6. Review.

PMID:
30082425
4.

Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.

Atherosclerosis. 2018 Jul;274:86-93. doi: 10.1016/j.atherosclerosis.2018.04.042. Epub 2018 Apr 30.

5.

High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, Hoogeveen RC, Jaar BG, Selvin E, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Coresh J, Hirsch AT.

Eur Heart J. 2018 Jul 1;39(25):2412-2419. doi: 10.1093/eurheartj/ehy106.

6.

PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study.

Smolderen KG, Gosch K, Patel M, Jones WS, Hirsch AT, Beltrame J, Fitridge R, Shishehbor MH, Denollet J, Vriens P, Heyligers J, Stone MEd N, Aronow H, Abbott JD, Labrosciano C, Tutein-Nolthenius R, A Spertus J.

Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e003860. doi: 10.1161/CIRCOUTCOMES.117.003860. Review.

PMID:
29440123
7.

Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.

Van't Hof JR, Duval S, Walts A, Kopecky SL, Luepker RV, Hirsch AT.

J Am Heart Assoc. 2017 Oct 3;6(10). pii: e006328. doi: 10.1161/JAHA.117.006328.

8.

A comparison of programmable and nonprogrammable compression devices for treatment of lymphoedema using an administrative health outcomes dataset.

Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH.

Br J Dermatol. 2017 Dec;177(6):1699-1707. doi: 10.1111/bjd.15699. Epub 2017 Nov 14.

PMID:
28573790
9.

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT; Cardiovascular Cell Therapy Research Network (CCTRN).

Circulation. 2017 Apr 11;135(15):1417-1428. doi: 10.1161/CIRCULATIONAHA.116.025707. Epub 2017 Feb 16.

10.

Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort.

Rapson IR, Michos ED, Alonso A, Hirsch AT, Matsushita K, Reis JP, Lutsey PL.

Atherosclerosis. 2017 Feb;257:123-129. doi: 10.1016/j.atherosclerosis.2017.01.016. Epub 2017 Jan 16.

11.

Lower Extremity Peripheral Artery Disease and Quality of Life Among Older Individuals in the Community.

Wu A, Coresh J, Selvin E, Tanaka H, Heiss G, Hirsch AT, Jaar BG, Matsushita K.

J Am Heart Assoc. 2017 Jan 20;6(1). pii: e004519. doi: 10.1161/JAHA.116.004519.

12.

Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study.

Matsushita K, Ballew SH, Sang Y, Kalbaugh C, Loehr LR, Hirsch AT, Tanaka H, Heiss G, Windham BG, Selvin E, Coresh J.

Atherosclerosis. 2017 Feb;257:208-215. doi: 10.1016/j.atherosclerosis.2016.11.023. Epub 2016 Nov 23.

13.

Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study.

Venkatesh BA, Nauffal V, Noda C, Fujii T, Yang PC, Bettencourt J, Ricketts EP, Murphy M, Leeper NJ, Moyé L, Ebert RF, Muthupillai R, Bluemke DA, Perin EC, Hirsch AT, Lima JA; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2017 Jan;183:24-34. doi: 10.1016/j.ahj.2016.09.013. Epub 2016 Oct 2.

14.

The conundrum of ALI and systemic embolic events: SEEing our way to improved vascular health.

Hirsch AT, Van't Hof JR, Bonaca M.

Vasc Med. 2016 Dec;21(6):535-538. Epub 2016 Nov 1. No abstract available.

PMID:
27807305
15.

Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions).

Murphy TP, Cooper CJ, Pencina KM, D'Agostino R, Massaro J, Cutlip DE, Jamerson K, Matsumoto AH, Henrich W, Shapiro JI, Tuttle KR, Cohen DJ, Steffes M, Gao Q, Metzger DC, Abernethy WB, Textor SC, Briguglio J, Hirsch AT, Tobe S, Dworkin LD.

Hypertension. 2016 Nov;68(5):1145-1152. Epub 2016 Sep 19.

16.

Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia.

Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, Marston W, Pyun WB, Min SK, Peterson BG, Comerota A, Choi D, Ballard J, Bartow RA, Losordo DW, Sherman W, Driver V, Perin EC.

Gene Ther. 2016 Apr;23(4):399. doi: 10.1038/gt.2016.9. No abstract available.

PMID:
27052927
17.

Exercise and Physical Activity for the Post-Aortic Dissection Patient: The Clinician's Conundrum.

Chaddha A, Eagle KA, Braverman AC, Kline-Rogers E, Hirsch AT, Brook R, Jackson EA, Woznicki EM, Housholder-Hughes S, Pitler L, Franklin BA.

Clin Cardiol. 2015 Nov;38(11):647-51. doi: 10.1002/clc.22481.

18.

Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.

Michaud TL, Abraham J, Jalal H, Luepker RV, Duval S, Hirsch AT.

J Am Heart Assoc. 2015 Dec 23;4(12). pii: e002321. doi: 10.1161/JAHA.115.002321.

19.

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey.

Luepker RV, Steffen LM, Duval S, Zantek ND, Zhou X, Hirsch AT.

J Am Heart Assoc. 2015 Dec 23;4(12). pii: e002320. doi: 10.1161/JAHA.115.002320.

20.

Nutritional status and body composition in patients with peripheral arterial disease: A cross-sectional examination of disease severity and quality of life.

Brostow DP, Hirsch AT, Pereira MA, Bliss RL, Kurzer MS.

Ecol Food Nutr. 2016;55(1):87-109. doi: 10.1080/03670244.2015.1072817. Epub 2015 Dec 11.

21.

Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia.

Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, Marston W, Pyun WB, Min SK, Peterson BG, Comerota A, Choi D, Ballard J, Bartow RA, Losordo DW, Sherman W, Driver V, Perin EC.

Gene Ther. 2016 Mar;23(3):306-12. doi: 10.1038/gt.2015.110. Epub 2015 Dec 8. Erratum in: Gene Ther. 2016 Apr;23(4):399.

PMID:
26649448
22.

The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema.

Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH.

JAMA Dermatol. 2015 Nov;151(11):1187-93. doi: 10.1001/jamadermatol.2015.1895.

PMID:
26444458
23.

The effect of gender on outcomes of aortoiliac artery interventions for claudication.

Krishnamurthy VN, Naeem M, Murphy TP, Cerezo J, Jordan PG, Goldberg SH, Ershow AG, Hirsch AT, Oldenburg N, Cutlip DE.

Clin Imaging. 2016 Jan-Feb;40(1):96-100. doi: 10.1016/j.clinimag.2015.09.003. Epub 2015 Sep 4.

24.

The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease: A State-Based Cohort Analysis.

Duval S, Long KH, Roy SS, Oldenburg NC, Harr K, Fee RM, Sharma RR, Alesci NL, Hirsch AT.

J Am Coll Cardiol. 2015 Oct 6;66(14):1566-1574. doi: 10.1016/j.jacc.2015.06.1349.

25.

Recruiting older patients with peripheral arterial disease: evaluating challenges and strategies.

Brostow DP, Hirsch AT, Kurzer MS.

Patient Prefer Adherence. 2015 Aug 6;9:1121-8. doi: 10.2147/PPA.S83306. eCollection 2015.

26.

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes.

Bekwelem W, Connolly SJ, Halperin JL, Adabag S, Duval S, Chrolavicius S, Pogue J, Ezekowitz MD, Eikelboom JW, Wallentin LG, Yusuf S, Hirsch AT.

Circulation. 2015 Sep 1;132(9):796-803. doi: 10.1161/CIRCULATIONAHA.114.013243. Epub 2015 Jul 29.

PMID:
26224811
27.

Movement, Function, Pain, and Postoperative Edema in Axillary Web Syndrome.

Koehler LA, Blaes AH, Haddad TC, Hunter DW, Hirsch AT, Ludewig PM.

Phys Ther. 2015 Oct;95(10):1345-53. doi: 10.2522/ptj.20140377. Epub 2015 May 14.

28.

Characterizing axillary web syndrome: ultrasonographic efficacy.

Koehler LA, Hunter DW, Haddad TC, Blaes AH, Hirsch AT, Ludewig PM.

Lymphology. 2014 Dec;47(4):156-63.

29.

Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER 3rd, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Jaff MR, Comerota AJ, Steffes MW, Abrahamsen IH, Goldberg S, Hirsch AT.

J Am Coll Cardiol. 2015 Mar 17;65(10):999-1009. doi: 10.1016/j.jacc.2014.12.043. Erratum in: J Am Coll Cardiol. 2015 May 12;65(18):2055.

30.

The Society for Vascular Medicine: the first quarter century.

Creager MA, Hiatt WR, Hirsch AT, Olin JW, Jaff MR, Cooke JP, Rooke T, Beckman JA, Froehlich JB.

Vasc Med. 2015 Feb;20(1):60-8. doi: 10.1177/1358863X14566042.

PMID:
25722420
31.

Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.

Brayton KM, Hirsch AT, O Brien PJ, Cheville A, Karaca-Mandic P, Rockson SG.

PLoS One. 2014 Dec 3;9(12):e114597. doi: 10.1371/journal.pone.0114597. eCollection 2014.

32.

Development of administrative data algorithms to identify patients with critical limb ischemia.

Bekwelem W, Bengtson LG, Oldenburg NC, Winden TJ, Keo HH, Hirsch AT, Duval S.

Vasc Med. 2014 Dec;19(6):483-90. doi: 10.1177/1358863X14559589.

PMID:
25447239
33.

Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.

Garimella PS, Hirsch AT.

Adv Chronic Kidney Dis. 2014 Nov;21(6):460-71. doi: 10.1053/j.ackd.2014.07.005. Epub 2014 Oct 24. Review.

34.

Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.

Perin EC, Murphy M, Cooke JP, Moyé L, Henry TD, Bettencourt J, Gahremanpour A, Leeper N, Anderson RD, Hiatt WR, Lima JA, Venkatesh B, Sayre SL, Vojvodic RW, Taylor DA, Ebert RF, Hirsch AT; Cardiovascular Cell Therapy Research Network.

Am Heart J. 2014 Nov;168(5):667-73. doi: 10.1016/j.ahj.2014.07.021. Epub 2014 Jul 30.

35.

Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.

Reynolds MR, Apruzzese P, Galper BZ, Murphy TP, Hirsch AT, Cutlip DE, Mohler ER 3rd, Regensteiner JG, Cohen DJ.

J Am Heart Assoc. 2014 Nov 11;3(6):e001233. doi: 10.1161/JAHA.114.001233.

36.

Cardiology patient page. Activity recommendations for postaortic dissection patients.

Chaddha A, Kline-Rogers E, Woznicki EM, Brook R, Housholder-Hughes S, Braverman AC, Pitler L, Hirsch AT, Eagle KA.

Circulation. 2014 Oct 14;130(16):e140-2. doi: 10.1161/CIRCULATIONAHA.113.005819. No abstract available.

PMID:
25311622
37.

The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registry.

Duval S, Keo HH, Oldenburg NC, Baumgartner I, Jaff MR, Peacock JM, Tretinyak AS, Henry TD, Luepker RV, Hirsch AT.

Am Heart J. 2014 Oct;168(4):577-87. doi: 10.1016/j.ahj.2014.06.013. Epub 2014 Jun 24.

PMID:
25262269
38.

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease.

Bauer TA, Wolff AA, Hirsch AT, Meng LL, Rogers K, Malik FI, Hiatt WR.

Vasc Med. 2014 Aug;19(4):297-306. Epub 2014 May 28.

PMID:
24872402
39.

A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.

Oldenburg NC, Duval S, Luepker RV, Finnegan JR, LaMarre H, Peterson KA, Zantek ND, Jacobs G, Straka RJ, Miller KH, Hirsch AT.

Prev Chronic Dis. 2014 May 15;11:E83. doi: 10.5888/pcd11.130378.

40.

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.

Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT.

J Vasc Surg. 2014 Sep;60(3):686-95.e2. doi: 10.1016/j.jvs.2014.03.290. Epub 2014 May 10.

41.

Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events.

Fowkes FG, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, Debacker G, Kornitzer M, Newman AB, Sutton-Tyrrell KC, Cushman M, Lee AJ, Price JF, D'Agostino RB Sr, Murabito JM, Norman P, Masaki KH, Bouter LM, Heine RJ, Stehouwer CD, McDermott MM, Stoffers HE, Knottnerus JA, Ogren M, Hedblad B, Koenig W, Meisinger C, Cauley JA, Franco O, Hunink MG, Hofman A, Witteman JC, Criqui MH, Langer RD, Hiatt WR, Hamman RF; Ankle Brachial Index Collaboration.

Eur J Prev Cardiol. 2014 Mar;21(3):310-20. doi: 10.1177/2047487313516564. Epub 2013 Dec 23.

42.

The FReedom from Ischemic Events-New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease.

Keo HH, Duval S, Baumgartner I, Oldenburg NC, Jaff MR, Goldman J, Peacock JM, Tretinyak AS, Henry TD, Luepker RV, Hirsch AT.

BMC Cardiovasc Disord. 2013 Dec 19;13:120. doi: 10.1186/1471-2261-13-120.

43.

Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes.

Muluk SC, Hirsch AT, Taffe EC.

Eur J Vasc Endovasc Surg. 2013 Oct;46(4):480-7. doi: 10.1016/j.ejvs.2013.07.012. Epub 2013 Aug 21.

44.

The global pandemic of peripheral artery disease.

Hirsch AT, Duval S.

Lancet. 2013 Oct 19;382(9901):1312-4. doi: 10.1016/S0140-6736(13)61576-7. Epub 2013 Aug 1. No abstract available.

PMID:
23915884
45.

Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

Murphy TP, Reynolds MR, Cohen DJ, Regensteiner JG, Massaro JM, Cutlip DE, Mohler ER, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Hirsch AT.

J Vasc Interv Radiol. 2013 Oct;24(10):1427-35; quiz 1436. doi: 10.1016/j.jvir.2013.05.057. Epub 2013 Jul 29.

46.

Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement.

Zantek ND, Luepker RV, Duval S, Miller K, Oldenburg N, Hirsch AT.

Clin Appl Thromb Hemost. 2014 May;20(4):385-92. doi: 10.1177/1076029613486537. Epub 2013 May 7.

PMID:
23653145
47.

Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.

Misra S, Lookstein R, Rundback J, Hirsch AT, Hiatt WR, Jaff MR, White CR, Conte M, Geraghty P, Patel M, Rosenfield K.

J Vasc Interv Radiol. 2013 Apr;24(4):451-8. doi: 10.1016/j.jvir.2012.10.028. No abstract available.

48.

Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L, Golzarian J, Gornik HL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE; American College of Cardiology Foundation Task Force; American Heart Association Task Force.

J Am Coll Cardiol. 2013 Apr 9;61(14):1555-70. doi: 10.1016/j.jacc.2013.01.004. Epub 2013 Mar 6. No abstract available.

49.

Effective vascular therapeutics for critical limb ischemia: a role for registry-based clinical investigation.

Hirsch AT, Duval S.

Circ Cardiovasc Interv. 2013 Feb;6(1):8-11. doi: 10.1161/CIRCINTERVENTIONS.113.000127. No abstract available.

PMID:
23424269
50.

The role of nutrition and body composition in peripheral arterial disease.

Brostow DP, Hirsch AT, Collins TC, Kurzer MS.

Nat Rev Cardiol. 2012 Nov;9(11):634-43. doi: 10.1038/nrcardio.2012.117. Epub 2012 Aug 28. Review.

Supplemental Content

Loading ...
Support Center